Fropenem clinical trials
Also written Faropenem.
How each study uses fropenem is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Other names
- Faropenem
- 5
Studies by the year they started
5 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 3
National University Hospital, Singapore (2) · Dr. Md. Alimur Reza (1) · TASK Applied Science (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)
Often tested with
Tested in the same studies.
Amoxicillin (2) · Clavulanic Acid (2) · Cefadroxil (1) · Meropenem (1) · Amoxicillin-Potassium Clavulanate Combination (1) · Rifampin (1)
Studies
Open first, then newest update. How each study uses fropenem is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)CompletedPhase 4Dr. Md. Alimur RezaNCT06804096Written as Faropenem
- Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel BiomarkersCompletedPhase 2National University Hospital, SingaporeNCT02381470Written as Faropenem
- Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary TuberculosisCompletedPhase 2TASK Applied ScienceNCT02349841Written as Faropenem
- Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy VolunteersCompletedPhase 1National University Hospital, SingaporeNCT02393586Written as Faropenem
- A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial PneumoniaStatus unknownPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT01937832Written as Faropenem
Codes
What other systems call fropenem · ClinicalTrials.gg INT004003
- MeSH (NLM) C107057fropenemOne source NLM
- UNII (FDA) F52Y83BGH3FAROPENEMConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C107057 | fropenem | One source NLM |
| UNII (FDA) | F52Y83BGH3 | FAROPENEM | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.